Push Admin

PH gov’t asking Japan for allocation of ‘promising' anti-flu drug vs COVID-19

Article (news)

Kristine Sabillo, ABS-CBN News

<div class="embed-wrap"><figure data-feedback="fb:likes,fb:comments"><img src="https://sa.kapamilya.com/absnews/abscbnnews/media/2020/reuters/01/29/lab.jpg"/><figcaption>A technician works in a laboratory for manufacturing testing kits for the new coronavirus at a medical laboratory company Da An Gene Co, as the country is hit by an outbreak of the new coronavirus, in Guangzhou, Guangdong province, China Jan. 28, 2020. Reuters</figcaption></figure></div>MANILA — The Philippine government has requested an anti-flu drug that is believed to be effective against COVID-19 from Japan, a health official said Monday. “The government is trying to ask the government of Japan to allocate Avigan for the Philippines, Health Undersecretary Eric Domingo told ABS-CBN News.Avigan is the brand name for anti-flu drug favipiravir. The Chinese government has recently decided to officially use the Japanese-developed drug to treat patients with COVID-19.“Clinical studies in Japan show encouraging results,” said Domingo, who is also director general of the Food and Drug Administration, said.The Japanese government is already looking to officially approve Avigan as a treatment for COVID-19 once clinical trials conclude.However, it is not locally available in the Philippines.“There is no word yet from the manufacturer of Avigan so we do not yet know when it will be available here,” Domingo said.Avigan is among the drugs being tested worldwide as a treatment for COVID-19. Another drug that has shown promise is chloroquine, which was made to treat malaria.The Philippines is now studying the possibility of participating in the World Health Organization’s “Solidarity Trial,” which is a multi-country clinical trial program for COVID-19 treatment.<ul class="op-related-articles">	<li><a href="https://news.abs-cbn.com/news/03/30/20/ph-on-joining-world-health-organization-clinical-trial-for-coronavirus-covid19">READ: PH mulls over joining WHO’s ‘Solidarity Trial’ for COVID-19 cure</a></li></ul>As of Monday, there has been more than 700,000 cases of COVID-19 worldwide. More than 1,400 are in the Philippines.

The Philippine government has requested an anti-flu drug that is believed to be effective against COVID-19 from Japan, a health official said Monday.

The Philippine government has requested an anti-flu drug that is believed to be effective against COVID-19 from Japan, a health official said Monday.

PH gov’t asking Japan for allocation of ‘promising' anti-flu drug vs COVID-19

News

Entertainment

Lifestyle

Sports

Metro.Style

More

BINI

Sudoku

Word of the Day

Lotto

Horoscope

News

PH gov’t asking Japan for allocation of ‘promising' anti-flu drug vs COVID-19

Kristine Sabillo,

ABS-CBN News

Published March 30, 2020 02:59 PM PHT

Read More:

COVID-19

coronavirus

Department of Health

Avigan

COVID-19 cure

favipiravir

ABS-CBN Newsletter

Your go-to source for the latest news, entertainment highlights, exclusive interviews, and updates on your favorite Kapamilya stars.

ABS-CBN Newsletter

Your go-to source for the latest news, entertainment highlights, exclusive interviews, and updates on your favorite Kapamilya stars.

Sign Up

I have read and agree to the Terms and Privacy Policy.

Haven't received our newsletter?

Check your inbox to verify and confirm your subscription.

ABS-CBN is the leading media and entertainment company in the Philippines, offering quality content across TV, radio, digital, and film. Committed to public service and promoting Filipino values, ABS-CBN continues to inspire and connect audiences worldwide.

Corporate

Investors

Governance

International Distribution

Corporate

Governance

Investors

International Distribution

NPC Seal of Registration

Privacy Policy

AI Policy

Terms of Service

Advertise with Us

© 2026 ABS-CBN Corporation. All Rights Reserved.

NPC Seal of Registration

Privacy Policy

Terms of Service

AI Policy

Advertise with Us

© 2026 ABS-CBN Corporation. All Rights Reserved.

NPC Seal of Registration

Privacy Policy

Terms of Service

AI Policy

Advertise with Us

© 2026 ABS-CBN Corporation. All Rights Reserved.